Post date: 
Wednesday, 20 September 2017

Ten people with Retinitis Pigmentosa are being asked to review the benefits of an eye implant.

Selected applicants will take part in the evaluation of the small implant, called Argus II, or the ‘bionic eye’, which will be surgically fitted into their retina. 
Following the surgery, participants of the evaluation will receive rehabilitation for one year to help them use the technology on a day to day basis. The evaluation will gather the patient's feedback about how the implant has made a difference to their lives.
How does Argus II work?
The Argus II implant communicates with a camera mounted on a pair of glasses by sending wireless signals direct to the nerves which control sight. The signals are then ‘decoded’ by the brain as flashes of light.
To date, over 250 patients with Retinitis Pigmentosa (RP) across the UK, US, Germany, France and Switzerland have received the Argus II implant.

Jeroen Perk, 37, had Argus II fitted in 2013. He said: “Argus II helps me to be more confident generally in life. With the system, it is much easier for me to get around outside because I can sense where obstacles and road crossings are.”

A keen skier, Jeroen added: “It is easier for me to see the outlines of objects when the atmosphere is full of light. I can’t see details, but it helps me navigate. Using the Argus II system is like a new chapter in my life.”  
How to get involved
Eligible patients with RP will undergo an initial interview and selection process to find the most appropriate candidates for the trial. The surgery will be carried out at Moorfields Eye Hospital and Manchester Royal Eye Hospital.
For more information about the trial, please call Freephone 0800 520 0925 (answerphone call back service outside of office hours).
Further information
NB News (archive)